NanoPass Secures Series B Investment to Accelerate Commercialization of its Intradermal Delivery Products
7/30/2012 9:56:44 AM
More...
|
NanoPass Grants a License to its Intradermal Delivery Device to Circassia for Use in Multiple Allergy Vaccine Fields
9/15/2011 10:48:56 AM
More...
|
Infectious Disease Research Institute (IDRI) to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests
8/31/2009 1:29:36 PM
More...
|
New Microneedle-Based Injection Device From NanoPass
8/14/2009 7:24:01 AM
More...
|